Foundation Medicine Inc (FMI) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
150 SECOND STREET CAMBRIDGE, MA 02141 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 60,293 | 71,404 | 76,814 | 71,517 | 99,051 | 143,019 | |||
| Cash and cash equivalents | 60,293 | 71,404 | 76,814 | 36,532 | 49,075 | 63,617 | |||
| Short-term investments | 34,985 | 49,976 | 79,402 | ||||||
| Receivables | 41,321 | 30,126 | 15,496 | 17,727 | 10,728 | 10,213 | |||
| Inventory, net of allowances, customer advances and progress billings | 16,411 | 13,171 | 10,400 | 8,922 | 10,349 | 10,438 | |||
| Inventory | 16,411 | 13,171 | 10,400 | 8,922 | 10,349 | 10,438 | |||
| Contract with customer, asset, after allowance for credit loss | ✕ | ✕ | ✕ | ✕ | ✕ | ||||
| Other undisclosed current assets | 13,003 | 9,118 | 4,612 | 5,102 | 5,338 | 5,251 | |||
| Total current assets: | 131,028 | 123,819 | 107,322 | 103,268 | 125,466 | 168,921 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 41,607 | 41,119 | 39,136 | 38,713 | 39,553 | 41,486 | |||
| Restricted cash and investments | 2,305 | 2,305 | 2,305 | 2,305 | 1,395 | 1,395 | |||
| Other noncurrent assets | 2,225 | 1,760 | 1,796 | 2,080 | 2,140 | 2,233 | |||
| Other undisclosed noncurrent assets | |||||||||
| Total noncurrent assets: | 46,137 | 45,184 | 43,237 | 43,098 | 43,088 | 45,114 | |||
| TOTAL ASSETS: | 177,165 | 169,003 | 150,559 | 146,366 | 168,554 | 214,035 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 48,258 | 58,671 | 44,424 | 40,444 | 29,667 | 32,476 | |||
| Accounts payable | 25,865 | 21,926 | 16,178 | 15,175 | 10,427 | 11,898 | |||
| Accrued liabilities | 22,393 | 36,745 | 28,246 | 25,269 | 19,240 | 20,578 | |||
| Deferred rent credit | ✕ | ✕ | ✕ | ✕ | ✕ | ||||
| Deferred revenue and credits | ✕ | 4,703 | 4,030 | 3,141 | 3,310 | 4,403 | 4,428 | ||
| Other undisclosed current liabilities | 4,801 | 3,742 | 296 | 3,742 | 293 | 3,747 | |||
| Total current liabilities: | 57,762 | 66,443 | 47,861 | 47,496 | 34,363 | 40,651 | |||
| Noncurrent Liabilities | |||||||||
| Liabilities, other than long-term debt | 90,000 | 60,000 | 30,000 | ||||||
| Due to related parties | 90,000 | 60,000 | 30,000 | ||||||
| Total noncurrent liabilities: | 90,000 | 60,000 | 30,000 | ||||||
| Total liabilities: | 147,762 | 126,443 | 77,861 | 47,496 | 34,363 | 40,651 | |||
| Equity | |||||||||
| Equity, attributable to parent | 18,896 | 31,668 | 63,437 | 89,516 | 126,317 | 164,846 | |||
| Common stock | 4 | 4 | 4 | 4 | 4 | 4 | |||
| Additional paid in capital | 544,541 | 537,904 | 531,593 | 525,041 | 517,698 | 509,664 | |||
| Accumulated other comprehensive income (loss) | (177) | 109 | 78 | 65 | (49) | (14) | |||
| Accumulated deficit | (525,472) | (506,349) | (468,238) | (435,594) | (391,336) | (344,808) | |||
| Total equity: | 18,896 | 31,668 | 63,437 | 89,516 | 126,317 | 164,846 | |||
| Other undisclosed liabilities and equity | 10,507 | 10,892 | 9,261 | 9,354 | 7,874 | 8,538 | |||
| TOTAL LIABILITIES AND EQUITY: | 177,165 | 169,003 | 150,559 | 146,366 | 168,554 | 214,035 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 52,840 | 48,913 | 42,658 | 35,004 | 26,328 | 28,824 | ||
| Revenue, net | ✕ | ✕ | 26,328 | 28,824 | ||||
| Cost of revenue | (21,862) | (21,533) | (14,462) | (17,207) | (17,117) | (16,737) | ||
| Gross profit: | 30,978 | 27,380 | 28,196 | 17,797 | 9,211 | 12,087 | ||
| Operating expenses | (67,399) | (64,896) | (60,622) | (62,111) | (54,998) | (47,072) | ||
| Other undisclosed operating loss | (900) | (720) | ||||||
| Operating loss: | (36,421) | (37,516) | (32,426) | (44,314) | (46,687) | (35,705) | ||
| Nonoperating income | 60 | 144 | 96 | |||||
| Other nonoperating income | 60 | 144 | ||||||
| Interest and debt expense | 1 | |||||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 57 | |||||||
| Loss from continuing operations: | (36,421) | (37,515) | (32,366) | (44,314) | (46,543) | (35,552) | ||
| Loss before gain (loss) on sale of properties: | (36,421) | (37,515) | (32,366) | (44,314) | (46,543) | (35,552) | ||
| Net loss: | (36,421) | (37,515) | (32,366) | (44,314) | (46,543) | (35,552) | ||
| Other undisclosed net income (loss) attributable to parent | (994) | (596) | (278) | 56 | 90 | (57) | ||
| Net loss available to common stockholders, diluted: | (37,415) | (38,111) | (32,644) | (44,258) | (46,453) | (35,609) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 6/30/2018 Q2 | 3/31/2018 Q1 | 12/31/2017 Q4 | 9/30/2017 Q3 | 6/30/2017 Q2 | 3/31/2017 Q1 | 12/31/2016 Q4 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (36,421) | (37,515) | (32,366) | (44,314) | (46,543) | (35,552) | ||
| Other comprehensive income (loss) | (286) | 31 | 13 | 114 | (35) | (48) | ||
| Comprehensive loss: | (36,707) | (37,484) | (32,353) | (44,200) | (46,578) | (35,600) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (994) | (596) | (278) | 56 | 90 | (57) | ||
| Comprehensive loss, net of tax, attributable to parent: | (37,701) | (38,080) | (32,631) | (44,144) | (46,488) | (35,657) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.